News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Abbott Laboratories (ABT) to Cut 3,000 Jobs Following Solvay Pharmaceuticals, Inc. Deal



9/21/2010 8:10:17 AM

NEW YORK, Sept 21 (Reuters) - Abbott Laboratories Inc (ABT.N) plans to cut 3,000 jobs, or about 3 percent of its workforce, following its purchase of Solvay's (SOLB.BR) pharmaceuticals business.

Read at Reuters
Read at Wall Street Journal
Read at Bloomberg
Read at Street Insider


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES